ArticleCNS neuroscience & therapeutics2024

First-in-Human Study of BAT4406F, an ADCC-Enhanced Fully Humanized Anti-CD20 Monoclonal Antibody in Patients With Neuromyelitis Optica Spectrum Disorders.

Hai Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.